These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 6549508)

  • 1. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R; Miranda GF; Verry M
    Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. d-Fenfluramine and salbutamol: two drugs causing anorexia through different neurochemical mechanisms.
    Garattini S; Samanin R
    Int J Obes; 1984; 8 Suppl 1():151-7. PubMed ID: 6534892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salbutamol, d-amphetamine and d-fenfluramine reduce sucrose intake in freely fed rats by acting on different neurochemical mechanisms.
    Borsini F; Bendotti C; Samanin R
    Int J Obes; 1985; 9(4):277-83. PubMed ID: 4066115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats.
    Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F; Garattini S
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):159-63. PubMed ID: 503247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
    Garattini S; Bizzi A; Caccia S; Mennini T
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of normal food intake in rats and dogs and inhibition of experimentally induced hyperphagia in rats by CM 57373 and fenfluramine.
    Miranda GF; Poggesi E; Bianchetti A; Unkovic J; Samanin R
    Eur J Pharmacol; 1988 May; 150(1-2):155-61. PubMed ID: 2456940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of hypothalamic endorphins after repeated injections of anorectics which release serotonin.
    Harsing LG; Yang HY; Costa E
    J Pharmacol Exp Ther; 1982 Dec; 223(3):689-94. PubMed ID: 6292396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of brain noradrenaline and dopamine in the anorectic activity of diethylpropion in rats: a comparison with d-amphetamine.
    Borsini F; Bendotti C; Carli M; Poggesi E; Samanin R
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):3-11. PubMed ID: 515507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of endogenous opiates in the tolerance to the anorectic effect of fenfluramine.
    Groppetti A; Parenti M; Dellavedova L; Tirone F
    J Pharmacol Exp Ther; 1984 Feb; 228(2):446-53. PubMed ID: 6694120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of D-fenfluramine in the rat.
    Samanin R; Mennini T; Bendotti C; Barone D; Caccia S; Garattini S
    Neuropharmacology; 1989 May; 28(5):465-9. PubMed ID: 2566947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anorectic drugs and prior feeding on food-rewarded runway behavior.
    Thurlby PL; Samanin R
    Pharmacol Biochem Behav; 1981 Jun; 14(6):799-804. PubMed ID: 7255515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system.
    Garattini S; Mennini T; Bendotti C; Invernizzi R; Samanin R
    Appetite; 1986; 7 Suppl():15-38. PubMed ID: 2427023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanisms of tolerance to the anorectic effect of salbutamol in rats.
    Bendotti C; Borsini F; Samanin R
    Eur J Pharmacol; 1983 Sep; 92(3-4):237-42. PubMed ID: 6138263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats.
    Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F
    Eur J Pharmacol; 1980 Jan; 61(2):203-6. PubMed ID: 7353591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for 5-HT2 receptor mediation in quipazine anorexia.
    Shukla R; MacKenzie-Taylor D; Rech RH
    Psychopharmacology (Berl); 1990; 100(1):115-8. PubMed ID: 2296618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system.
    Garattini S; Bizzi A; Codegoni AM; Caccia S; Mennini T
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):160S-166S. PubMed ID: 1728827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anorexigenic effects of d-amphetamine and l-DOPA in the rat.
    Sanghvi IS; Singer G; Friedman E; Gershon S
    Pharmacol Biochem Behav; 1975; 3(1):81-6. PubMed ID: 1129359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclo(His-Pro) potentiates the reduction of food intake induced by amphetamine, fenfluramine, or serotonin.
    Kow LM; Pfaff DW
    Pharmacol Biochem Behav; 1991 Feb; 38(2):365-9. PubMed ID: 2057504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral and central mechanisms of action of serotoninergic anorectic drugs.
    Carruba MO; Mantegazza P; Memo M; Missale C; Pizzi M; Spano PF
    Appetite; 1986; 7 Suppl():105-13. PubMed ID: 3740835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to the anorectic effect of dexfenfluramine in rats: role of serotonin, cholecystokinin, and neuropeptide Y.
    Rowland NE
    Physiol Behav; 1994 Feb; 55(2):201-7. PubMed ID: 8153156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.